Frequencies of circulating IL-17-producing CD4+CD161+ T cells and CD4+CD161+ T cells correlate with disease activity in rheumatoid arthritis

References

• McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365: 2205–2219.
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7: 145–173.
   PubMed Web of Science ®Google Scholar
• Dolhain RJ, Heiden AN, Haar NT, Breedveld FC, Miltenburg AM. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum. 1996;39: 1961–1969.
   PubMed Web of Science ®Google Scholar
• Hamburg JP, Asmawidjaja PS, Davelaar N, Mus AM, Colin EM, Hazes JM et al. Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production. Arthritis Rheum. 2011;63: 73–83.
   PubMedGoogle Scholar
• Lubberts E, Koenders MI, Berg WB. The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res Ther. 2005;7: 29–37.
   PubMed Web of Science ®Google Scholar
• Waldburger JM, Firestein GS. Garden of therapeutic delights: new targets in rheumatic diseases. Arthritis Res Ther. 2009;11: 206.
   PubMed Web of Science ®Google Scholar
• Shen H, Goodall JC, Hill GJ. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009;60: 1647–1656.
   PubMed Web of Science ®Google Scholar
• Chen DY, Chen YM, Chen HH, Hsieh CW, Lin CC, Lan JL. Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-alpha therapy. Arthritis Res Ther. 2011;13: R126.
   PubMed Web of Science ®Google Scholar
• Colin EM, Asmawidjaja PS, Hamburg JP, Mus AM, Driel M, Hazes JM et al. 1,25-Dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum. 2010;62: 132–142.
   PubMed Web of Science ®Google Scholar
• Lanier LL, Chang C, Phillips JH. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J Immunol. 1994;153: 2417–2428..
   PubMed Web of Science ®Google Scholar
• Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol. 2007;25: 297–336.
   PubMed Web of Science ®Google Scholar
• Godfrey DI, Berzins SP. Control points in NKT-cell development. Nat Rev Immunol. 2007;7: 505–518.
   PubMed Web of Science ®Google Scholar
• Cosmi L, Palma R, Santarlasci V, Maggi L, Capone M, Frosali F et al. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med. 2008;205: 1903–1916.
   PubMed Web of Science ®Google Scholar
• Maggi L, Santarlasci V, Capone M, Peired A, Frosali F, Crome SQ et al. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur J Immunol. 2010;40: 2174–2181.
   PubMed Web of Science ®Google Scholar
• Kleinschek MA, Boniface K, Sadekova S, Grein J, Murphy EE, Turner SP et al. Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med. 2009;206: 525–534.
   PubMed Web of Science ®Google Scholar
• Cosmi L, Cimaz R, Maggi L, Santarlasci V, Capone M, Borriello F et al. Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum. 2011;63: 2504–2515.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31: 315–324.
   PubMed Web of Science ®Google Scholar
• Prevoo ML, Hof M, Kuper HH, Leeuwen MA, Putte LB, Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38: 44–48.
   PubMed Web of Science ®Google Scholar
• Vrijhoef HJ, Diederiks JP, Spreeuwenberg C, Linden S. Applying low disease activity criteria using the DAS28 to assess stability in patients with rheumatoid arthritis. Ann Rheum Dis. 2003;62: 419–422.
   PubMed Web of Science ®Google Scholar
• Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009;361: 888–898.
   PubMed Web of Science ®Google Scholar
• Shahrara S, Huang Q, Mandelin AN, Pope RM. TH-17 cells in rheumatoid arthritis. Arthritis Res Ther. 2008;10: R93.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol. 2007;8: 345–350.
   PubMed Web of Science ®Google Scholar
• Chabaud M, Lubberts E, Joosten L, Berg W, Miossec P. IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis. Arthritis Res. 2001;3: 168–177.
   PubMedGoogle Scholar
• Raza K, Falciani F, Curnow SJ, Ross EJ, Lee CY, Akbar AN et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther. 2005;7: R784–R795.
   PubMed Web of Science ®Google Scholar
• Koenders MI, Berg WB. Translational mini-review series on Th17 cells: are T helper 17 cells really pathogenic in autoimmunity?. Clin Exp Immunol. 2010;159: 131–136.
   PubMed Web of Science ®Google Scholar
• Yamada H, Nakashima Y, Okazaki K, Mawatari T, Fukushi J, Oyamada A et al. Preferential accumulation of activated Th1 cells not only in rheumatoid arthritis but also in osteoarthritis joints. J Rheumatol. 2011;38: 1569–1575.
   PubMed Web of Science ®Google Scholar
• Poggi A, Costa P, Zocchi MR, Moretta L. Phenotypic and functional analysis of CD4+NKRP1A+ human T lymphocytes. Direct evidence that the NKRP1A molecule is involved in transendothelial migration. Eur J Immunol. 1997;27: 2345–2350.
   PubMed Web of Science ®Google Scholar
• Poggi A, Zocchi MR, Carosio R, Ferrero E, Angelini DF, Galgani S et al. Transendothelial migratory pathways of V delta 1+TCR gamma delta+ and V delta 2+TCR gamma delta+ T lymphocytes from healthy donors and multiple sclerosis patients: involvement of phosphatidylinositol 3 kinase and calcium calmodulin-dependent kinase II. J Immunol. 2002;168: 6071–6077..
   PubMed Web of Science ®Google Scholar
• Huarte E, Cubillos-Ruiz JR, Nesbeth YC, Scarlett UK, Martinez DG, Engle XA et al. PILAR is a novel modulator of human T-cell expansion. Blood. 2008;112: 1259–1268.
   PubMed Web of Science ®Google Scholar
• Poggi A, Canevali P, Contatore M, Ciprandi G. Higher frequencies of CD161+ circulating T lymphocytes in allergic rhinitis patients compared to healthy donors. Int Arch Allergy Immunol. 2012;158: 151–156.
   PubMed Web of Science ®Google Scholar